Format

Send to

Choose Destination
Nat Genet. 2019 Jan 8. doi: 10.1038/s41588-018-0330-6. [Epub ahead of print]

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR1,2,3, Olama AAA4,5,6, Berndt SI7,3, Benlloch S8,9, Ahmed M9, Saunders EJ9, Dadaev T9, Leongamornlert D9, Anokian E9, Cieza-Borrella C9, Goh C9, Brook MN9, Sheng X10, Fachal L11,12, Dennis J8, Tyrer J8, Muir K13,14, Lophatananon A13,14, Stevens VL15, Gapstur SM15, Carter BD15, Tangen CM16, Goodman PJ16, Thompson IM Jr17, Batra J18,19, Chambers S20,21, Moya L18,19, Clements J18,19, Horvath L22,23, Tilley W24, Risbridger GP25,26, Gronberg H27, Aly M28,29, Nordström T27,30, Pharoah P8,12, Pashayan N12,31, Schleutker J32,33, Tammela TLJ34, Sipeky C32, Auvinen A35, Albanes D7, Weinstein S7, Wolk A36,37, Håkansson N36, West CML38, Dunning AM12, Burnet N39, Mucci LA40, Giovannucci E40, Andriole GL41, Cussenot O42,43, Cancel-Tassin G42,43, Koutros S7, Beane Freeman LE7, Sorensen KD44,45, Orntoft TF44,45, Borre M45,46, Maehle L47, Grindedal EM47, Neal DE48,49,50, Donovan JL51, Hamdy FC50, Martin RM51, Travis RC52, Key TJ52, Hamilton RJ53, Fleshner NE53, Finelli A54, Ingles SA10, Stern MC10, Rosenstein BS55,56, Kerns SL57, Ostrer H58, Lu YJ59, Zhang HW60, Feng N61, Mao X59, Guo X62, Wang G63, Sun Z64, Giles GG65,66, Southey MC67, MacInnis RJ65,66, FitzGerald LM65,68, Kibel AS69, Drake BF41, Vega A11, Gómez-Caamaño A70, Szulkin R71,72, Eklund M27, Kogevinas M73,74,75,76, Llorca J74,77, Castaño-Vinyals G73,74,75,76, Penney KL78, Stampfer M78, Park JY79, Sellers TA79, Lin HY80, Stanford JL81,82, Cybulski C83, Wokolorczyk D83, Lubinski J83, Ostrander EA84, Geybels MS81, Nordestgaard BG85,86, Nielsen SF85,86, Weischer M86, Bisbjerg R87, Røder MA88, Iversen P88, Brenner H89,90,91, Cuk K89, Holleczek B92, Maier C93, Luedeke M93, Schnoeller T94, Kim J95, Logothetis CJ95, John EM96,97, Teixeira MR98,99, Paulo P98, Cardoso M98, Neuhausen SL100, Steele L100, Ding YC100, De Ruyck K101, De Meerleer G101, Ost P102, Razack A103, Lim J103, Teo SH104, Lin DW81,105, Newcomb LF81,105, Lessel D106, Gamulin M107, Kulis T108, Kaneva R109, Usmani N110,111, Singhal S110,111, Slavov C112, Mitev V109, Parliament M110,111, Claessens F113, Joniau S114, Van den Broeck T113,114, Larkin S115, Townsend PA116, Aukim-Hastie C117, Gago-Dominguez M118,119, Castelao JE120, Martinez ME121, Roobol MJ122, Jenster G122, van Schaik RHN123, Menegaux F124, Truong T124, Koudou YA124, Xu J125, Khaw KT126, Cannon-Albright L127,128, Pandha H117, Michael A117, Thibodeau SN129, McDonnell SK130, Schaid DJ130, Lindstrom S82, Turman C131, Ma J78, Hunter DJ131, Riboli E132, Siddiq A133, Canzian F134, Kolonel LN135, Le Marchand L135, Hoover RN7, Machiela MJ7, Cui Z1, Kraft P131, Amos CI136,137,138, Conti DV10, Easton DF8,12, Wiklund F27, Chanock SJ7, Henderson BE10, Kote-Jarai Z9, Haiman CA10, Eeles RA139,140; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Author information

1
Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
2
Seidman Cancer Center, University Hospitals, Cleveland, OH, USA.
3
Royal Marsden NHS Foundation Trust, London, UK.
4
Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. aa461@medschl.cam.ac.uk.
5
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. aa461@medschl.cam.ac.uk.
6
Royal Marsden NHS Foundation Trust, London, UK. aa461@medschl.cam.ac.uk.
7
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
8
Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
9
Institute of Cancer Research, London, UK.
10
Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
11
Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain.
12
Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.
13
Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
14
Warwick Medical School, University of Warwick, Coventry, UK.
15
Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.
16
SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
17
CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA.
18
Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
19
Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.
20
Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia.
21
Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
22
Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia.
23
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
24
Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia.
25
Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia.
26
Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
27
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
28
Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
29
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
30
Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.
31
Department of Applied Health Research, University College London, London, UK.
32
Institute of Biomedicine, University of Turku, Turku, Finland.
33
Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
34
Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
35
Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.
36
Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
37
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
38
Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
39
Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
40
Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA.
41
Washington University School of Medicine, St. Louis, MO, USA.
42
UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France.
43
CeRePP, Tenon Hospital, Paris, France.
44
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
45
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
46
Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
47
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
48
Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
49
Cancer Research UK, Cambridge Research Institute, Cambridge, UK.
50
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK.
51
School of Social and Community Medicine, University of Bristol, Bristol, UK.
52
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
53
Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
54
Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
55
Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
56
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
57
Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.
58
Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.
59
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
60
Second Military Medical University, Shanghai, China.
61
Wuxi Second Hospital, Nanjing Medical University, Wuxi, China.
62
Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
63
Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China.
64
People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China.
65
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
66
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
67
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
68
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
69
Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA.
70
Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
71
Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden.
72
Scandinavian Development Services, Danderyd, Sweden.
73
ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
74
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
75
IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
76
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
77
University of Cantabria-IDIVAL, Santander, Spain.
78
Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
79
Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
80
Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
81
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
82
Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
83
International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
84
National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
85
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
86
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
87
Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
88
Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
89
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
90
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
91
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
92
Saarland Cancer Registry, Saarbrücken, Germany.
93
Institute for Human Genetics, University Hospital Ulm, Ulm, Germany.
94
Department of Urology, University Hospital Ulm, Ulm, Germany.
95
Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.
96
Cancer Prevention Institute of California, Fremont, CA, USA.
97
Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
98
Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.
99
Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
100
Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
101
Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium.
102
Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.
103
Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
104
Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia.
105
Department of Urology, University of Washington, Seattle, WA, USA.
106
Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
107
Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia.
108
Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
109
Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.
110
Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
111
Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
112
Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria.
113
Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
114
Department of Urology, University Hospitals Leuven, Leuven, Belgium.
115
University of Southampton, Southampton General Hospital, Southampton, UK.
116
Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK.
117
University of Surrey, Guildford, Surrey, UK.
118
Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain.
119
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
120
Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
121
Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
122
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
123
Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
124
Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
125
Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
126
Clinical Gerontology Unit, University of Cambridge, Cambridge, UK.
127
Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
128
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.
129
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
130
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
131
Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
132
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
133
Genomics England, Queen Mary University of London, London, UK.
134
Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
135
Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
136
Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
137
Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
138
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
139
Institute of Cancer Research, London, UK. ros.eeles@icr.ac.uk.
140
Royal Marsden NHS Foundation Trust, London, UK. ros.eeles@icr.ac.uk.

Abstract

In the version of this article initially published, the name of author Manuela Gago-Dominguez was misspelled as Manuela Gago Dominguez. The error has been corrected in the HTML and PDF version of the article.

PMID:
30622367
DOI:
10.1038/s41588-018-0330-6

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center